Results of the Multi-Society ACLF Harmonization
Nov
2026
Description
Disseminate the Harmonization efforts that have resulted in key statements that will inform clinical practice and clinical trial design.
Presentations
2:05 PM
- 2:20 PM
Convention Center - Mile High Ballroom 2A-3A
ACLF definition and grading
Paolo PA Angeli, MD, PhD | Presenter
2:30 PM
- 2:40 PM
Convention Center - Mile High Ballroom 2A-3A
Liver transplant and ACLF
Jacqueline G. O'Leary, MD, MPH | Presenter
2:40 PM
- 2:47 PM
Convention Center - Mile High Ballroom 2A-3A
Viral hepatitis
Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD | Presenter
2:47 PM
- 2:54 PM
Convention Center - Mile High Ballroom 2A-3A
Alcohol as a contributor to ACLF
Michael R Lucey, MD, FAASLD | Presenter
3:01 PM
- 3:16 PM
Convention Center - Mile High Ballroom 2A-3A
Endpoints for clinical trials
Jasmohan S. Bajaj, MD, FAASLD | Presenter
3:16 PM
- 3:30 PM
Convention Center - Mile High Ballroom 2A-3A
Q&A/Panel Discussion
Jasmohan S. Bajaj, MD, FAASLD | Moderator
2:54 PM
- 3:01 PM
Convention Center - Mile High Ballroom 2A-3A
DILI and ACLF
Gabriel Mezzano, MD | Presenter
